Varian Competitors

Delisted . USA . 
Stock . Varian Medical Systems
Varian Medical Systems competes with AG Mortgage, Aegon NV, Sun Life, SunOpta, and MGIC Investment; as well as few others. The company runs under Healthcare sector within Medical Instruments & Supplies industry. Analyzing Varian Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Varian Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Varian Medical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Varian Medical. Your research has to be compared to or analyzed against Varian Medical's peers to derive any actionable benefits. When done correctly, Varian Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Varian Medical Systems.

Varian Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Varian Medical and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Varian and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Varian Medical Systems does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
STKL
+ 0.8
SLF
MTG
+ 0.64
AEG
ASTVF
+ 0.45
AEG
MTG
+ 0.38
SLF
LHUAF
+ 0.32
ASTVF
STKL
+ 0.19
MITP
  
High negative correlations   
LHUAF
- 0.74
STKL
ASTVF
- 0.53
STKL
ASTVF
- 0.47
SLF
LHUAF
- 0.43
SLF
ASTVF
- 0.32
MITP
LHUAF
- 0.3
MITP

Risk-Adjusted Indicators

There is a big difference between Varian Stock performing well and Varian Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Varian Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Varian Medical Competitive Analysis

The better you understand Varian Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Varian Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Varian Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MITP AEG SLF STKL RFBC MTG ASTVF LHUAF
 1.92 
 25.00 
MITP
 0.61 
 6.50 
Aegon
 0.59 
 58.02 
Sun
 1.47 
 7.37 
SunOpta
 0.00 
 0.0001 
Romana
 0.63 
 25.47 
MGIC
 8.52 
 9.55 
Austevoll
 0.00 
 0.02 
Lianhua
Market Volatility
(90 Days Market Risk)
Very steady
Not too volatile
Very steady
Somewhat reliable
Very steady
Very steady
Not too volatile
Very steady
Market Performance
(90 Days Performance)
OK
Insignificant
Modest
OK
Very Weak
OK
Modest
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Below Average
Low
Below Average
Quite High
Low
Low
Quite High
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Sell
Buy
Buy
Strong Buy
Not Available
Buy
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Sell
Strong Sell
Current Ratio
N/A
1.39 X
811.07 X
2.18 X
N/A
2.68 X
2.36 X
0.48 X
Net Asset
N/A
301.58 B
333.24 B
669.42 M
N/A
6.54 B
43.78 B
22.83 B
Profit Margin
N/A
(0) %
0.11 %
(0.03) %
N/A
0.64 %
0.09 %
(0.02) %
EBITDA
N/A
(110 K)
3.8 B
38.22 M
N/A
902.23 M
6.28 B
10.84 M
Operating Margin
N/A
(0.01) %
0.21 %
0.05 %
N/A
0.86 %
0.20 %
(0.01) %
Current Valuation
N/A
11.58 B
30.88 B
1.29 B
10.86 K
6.77 B
2.41 B
416.38 M
Price To Book
N/A
1.20 X
1.92 X
5.46 X
N/A
1.21 X
1.15 X
0.52 X
Retained Earnings
N/A
5.1 B
12.16 B
(332.69 M)
(260.32 K)
4.59 B
4.49 B
N/A
Current Asset
N/A
59.37 B
N/A
597.05 M
N/A
N/A
11.71 B
N/A
Five Year Return
N/A
5.43 %
3.72 %
N/A
N/A
N/A
N/A
N/A
Beta
N/A
1.06
0.94
1.82
-1.52
1.27
0.88
0.72
Number Of Employees
N/A
15.7 K
30.94 K
1.17 K
N/A
627
21
29.45 K
Shares Outstanding
N/A
1.62 B
573.89 M
116.92 M
9.05 M
253.36 M
201.82 M
372.6 M
Cash Flow From Operations
N/A
864 M
5.61 B
14.84 M
(757)
712.96 M
4.56 B
995.6 M
Annual Yield
N/A
0.05 %
0.04 %
N/A
N/A
0.02 %
0.05 %
N/A
Total Debt
N/A
4.92 B
13.28 B
379.14 M
17.42 K
643.2 M
6.69 B
6.65 B
Return On Equity
N/A
-0.0138
0.15
-0.04
N/A
0.15
0.18
-0.23
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.0
Return On Asset
N/A
-4.0E-4
0.0089
0.0306
N/A
0.096
0.0823
-0.0082
Number Of Shares Shorted
N/A
6.49 M
1.55 M
4.91 M
N/A
10.11 M
N/A
N/A
Book Value Per Share
N/A
5.08 X
40.95 X
1.38 X
N/A
20.66 X
75.93 X
0.93 X
Current Liabilities
N/A
14.8 B
N/A
379.67 M
N/A
N/A
4.74 B
N/A
Total Asset
N/A
301.58 B
333.24 B
669.42 M
N/A
6.54 B
43.78 B
22.83 B
Debt To Equity
N/A
0.60 %
0.31 %
1.00 %
N/A
0.20 %
0.45 %
5.30 %
Short Ratio
N/A
1.21 X
3.84 X
9.02 X
N/A
5.95 X
N/A
N/A
Target Price
N/A
7.21
46.87
10.17
N/A
26.29
1.0
N/A
Last Dividend Paid
N/A
0.32
3.18
N/A
N/A
0.48
4.5
N/A
Shares Owned By Institutions
N/A
9.79 %
57.45 %
88.12 %
N/A
97.99 %
18.61 %
29.20 %
Market Capitalization
N/A
10.82 B
33.13 B
876.55 M
10.86 K
6.51 B
1.88 B
67.75 M
Price To Earning
N/A
18.40 X
14.03 X
12.59 X
N/A
10.50 X
27.25 X
(6.33) X
Price To Earnings To Growth
N/A
14.09 X
1.33 X
31.17 X
N/A
1.54 X
N/A
N/A
Price To Sales
N/A
0.85 X
1.02 X
1.23 X
N/A
5.47 X
0.06 X
0 X
Net Income
N/A
(346 M)
3.93 B
(21.91 M)
(25.4 K)
712.95 M
1.91 B
(422.78 M)
Earnings Per Share
N/A
(0.08) X
4.25 X
(0.07) X
N/A
2.83 X
1.33 X
(0.06) X
Shares Owned By Insiders
N/A
N/A
0.02 %
3.83 %
N/A
1.40 %
57.22 %
14.30 %
Revenue
N/A
29.54 B
32.66 B
630.3 M
N/A
1.16 B
26.57 B
24.76 B
Working Capital
N/A
44.56 B
N/A
29.84 M
N/A
N/A
6.96 B
N/A
Cash And Equivalents
N/A
1.58 B
6.31 B
553 K
N/A
327.38 M
4.35 B
4 B
Cash Per Share
N/A
10.05 X
141.27 X
N/A
N/A
1.35 X
21.55 X
3.57 X
Gross Profit
N/A
5.02 B
15.06 B
117.82 M
N/A
1.03 B
13.64 B
3.06 B
Day Typical Price
25.17
6.55
58.14
7.46
1.0E-4
25.43
9.55
0.0211
Accumulation Distribution
0.0196
0.0211
0.0259
0.0366
N/A
0.0214
N/A
N/A
Market Facilitation Index
0.5
0.14
1.53
0.28
N/A
0.55
N/A
N/A
Daily Balance Of Power
(0.98)
(0.29)
0.2222
(0.39)
0.0
0.2909
9.2 T
0.0
Period Momentum Indicator
(0.49)
(0.04)
0.34
(0.11)
N/A
0.16
0.75
N/A
Rate Of Daily Change
0.98
0.99
1.01
0.99
1.0
1.01
1.09
1.0
Day Median Price
25.25
6.57
58.2
7.51
1.0E-4
25.42
9.55
0.0211
Price Action Indicator
(0.49)
(0.09)
(0.01)
(0.20)
N/A
0.13
0.38
N/A
Coefficient Of Variation
816.08
3391.51
2202.88
626.26
N/A
10609.21
1501.44
(812.40)
Mean Deviation
0.1905
1.11
0.7315
1.63
N/A
1.1
0.256
2.25
Jensen Alpha
0.021
(0.01)
(0.01)
0.3539
N/A
0.0082
0.0673
(1.30)
Total Risk Alpha
(0.01)
(0.13)
(0.07)
0.1176
N/A
(0.17)
(0.06)
(2.15)
Sortino Ratio
(0.24)
(0.03)
(0.06)
0.1373
N/A
(0.05)
N/A
N/A
Downside Variance
0.0793
3.21
0.8468
4.52
N/A
3.4
N/A
N/A
Standard Deviation
0.2626
1.48
0.9919
2.45
N/A
1.6
1.14
9.26
Kurtosis
0.5148
2.72
2.59
6.88
N/A
2.91
49.24
66.0
Potential Upside
0.4781
1.79
1.41
3.82
N/A
2.24
N/A
N/A
Treynor Ratio
1.76
0.0685
0.0661
1.24
N/A
(0.14)
(4.31)
(0.70)
Maximum Drawdown
1.2
9.44
6.02
17.12
N/A
7.79
3.51
75.23
Variance
0.069
2.19
0.9838
6.01
N/A
2.55
1.3
85.76
Market Risk Adjusted Performance
1.77
0.0785
0.0761
1.25
N/A
(0.13)
(4.30)
(0.69)
Risk Adjusted Performance
0.0805
0.029
0.0395
0.14
N/A
0.0126
0.0583
(0.09)
Skewness
0.0746
(0.76)
0.6117
1.54
N/A
(0.75)
5.95
(8.12)
Semi Deviation
0.1722
1.65
0.8655
1.73
N/A
1.78
N/A
N/A
Information Ratio
(0.26)
(0.04)
(0.06)
0.1189
N/A
(0.05)
(0.02)
(0.13)
Value At Risk
(0.43)
(2.31)
(1.59)
(3.32)
N/A
(3.13)
N/A
N/A
Expected Short fall
(0.21)
(1.06)
(0.78)
(1.70)
N/A
(1.06)
N/A
N/A
Downside Deviation
0.2817
1.79
0.9202
2.12
N/A
1.84
N/A
N/A
Semi Variance
0.0296
2.72
0.7491
2.99
N/A
3.16
N/A
N/A

Varian Medical Competition Performance Charts

Five steps to successful analysis of Varian Medical Competition

Varian Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Varian Medical Systems in relation to its competition. Varian Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Varian Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Varian Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Varian Medical Systems, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Varian Medical position

In addition to having Varian Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Funds Thematic Idea Now

Healthcare Funds
Healthcare Funds Theme
Funds or Etfs investing in medical and healthcare goods or services as well as hospital management or maintenance organizations. The Healthcare Funds theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Varian Stock

If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY